Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIG Dose-Finding RCT in Severe SFTS
ChiCTR2600128408Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital, Anhui Medical University
- Start
- Jul 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of immune globulin in severe fever with thrombocytopenia syndrome (SFTS) (3 arms), sponsored by The First Affiliated Hospital, Anhui Medical University. Primary endpoints: 28-day case fatality rate and Incidence rate of adverse events. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
immune globulin
03
Conditions
severe fever with thrombocytopenia syndrome (SFTS)
Beyond the preview
Go deeper on ChiCTR2600128408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600128408.